The 33-year-old contracted the deadly virus while working in a Liberian Ebola ward with the aid agency Samaritan’s Purse. He was later brought to the U.S. earlier in the month.
He is the first ever Ebola patient to be treated in the U.S. and the first human to receive the experimental serum called ZMapp.
His condition, according to reports, was deteriorating that doctors in Liberia gave him the drug as a last effort to save him.
According to Samaritan’s Purse, Brantly’s condition started to improve dramatically within an hour after getting the serum.
After his health stabilized, he was taken from the country to Atlanta to the hospital isolation ward.
His coworker Nancy Writebol also survived after getting the serum and is still recovering at the Emory University Hospital.
